Explore All Access
Check if your research matches the topics covered in Cephalalgia Reports?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Cephalalgia Reports : Impact Factor & More
eISSN: 2515-8163
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Cephalalgia Reports Key Metrics
SJR 
Q4Neurology (clinical)
Time to Publish
View Chart Mo
Topics Covered on Cephalalgia Reports
Migraine
Functional connectivity
Cluster headache
New daily persistent headache
Episodic migraine
Sumatriptan
Cephalalgia Reports Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ
| Overview | |
| Publisher | SAGE |
| Language | English |
| Article Processing Charges | USD 1500 |
| Publication Time | 9 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors |
View less
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Time to Publish
% of papers by time taken from submission to publication
0 to 3 months44%
4 to 6 months56%
7 to 9 months0%
Above 9 months0%
Did you find this useful?
Planning to publish in Cephalalgia Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Cephalalgia Reports
Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center: A retrospective chart review study
- 1 Jan 2024
- Cephalalgia Reports
Rimegepant as an acute treatment in a refractory migraine patient non-responder to two anti-CGRP monoclonal antibodies and triptans: Case report and pharmacological considerations
- 1 Jan 2024
- Cephalalgia Reports
Paranoid psychosis after a single parenteral dose of indomethacin administered for headache diagnosis: A case and review of the literature
- 1 Jan 2024
- Cephalalgia Reports
Protocol of a cross-sectional, multicentre and multidisciplinary study describing phenotype and burden of a midfacial segment pain
- 1 Jan 2024
- Cephalalgia Reports
Corrigendum to “Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies”
- 1 Jan 2024
- Cephalalgia Reports
A century of bruxism research in top-ranking medical journals
- 1 Jan 2024
- Cephalalgia Reports
Real-world effectiveness of add-on fremanezumab in patients receiving onabotulinumtoxinA for the prevention of chronic migraine in a US tertiary headache center: A retrospective chart review study
- 1 Jan 2024
- Cephalalgia Reports
Rimegepant as an acute treatment in a refractory migraine patient non-responder to two anti-CGRP monoclonal antibodies and triptans: Case report and pharmacological considerations
- 1 Jan 2024
- Cephalalgia Reports
Paranoid psychosis after a single parenteral dose of indomethacin administered for headache diagnosis: A case and review of the literature
- 1 Jan 2024
- Cephalalgia Reports
Protocol of a cross-sectional, multicentre and multidisciplinary study describing phenotype and burden of a midfacial segment pain
- 1 Jan 2024
- Cephalalgia Reports
Corrigendum to “Eptinezumab administered intravenously, subcutaneously, or intramuscularly in healthy subjects and/or patients with migraine: Early development studies”
- 1 Jan 2024
- Cephalalgia Reports
A century of bruxism research in top-ranking medical journals
- 1 Jan 2024
- Cephalalgia Reports
Compare Similar Journals with Cephalalgia Reports
Select Journals to Compare with Cephalalgia Reports
Total journals - 10
You can select up to 3 Journals at a time
Cephalalgia
Publisher: SAGE PUBLICATIONS LTD
Journal of Headache and Pain
Publisher: BMC
Headache
Publisher: WILEY
Neurological Sciences
Publisher: SPRINGER-VERLAG ITALIA SRL
Current Pain and Headache Reports
Publisher: SPRINGER
Frontiers in Neurology
Publisher: FRONTIERS MEDIA SA
Journal of Neurology
Publisher: SPRINGER HEIDELBERG
BMC Neurology
Publisher: BMC
Neurology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Pain
Publisher: LIPPINCOTT WILLIAMS & WILKINS
0 Journals Selected to compare with
Cephalalgia Reports
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Cephalalgia Reports
How many articles did Cephalalgia Reports publish last year? 
In 2023, Cephalalgia Reports publsihed 10 articles.
What is the SJR for Cephalalgia Reports?
SJR for Cephalalgia Reports is Q4.
Who is the publisher of Cephalalgia Reports?
SAGE is the publisher of Cephalalgia Reports.
